The Significance of Brain Metastases in Non-Small Cell Lung Cancer
March 21st 2018Robert C. Doebele, MD, PhD, associate professor in the Division of Medical Oncology at the University of Colorado, discusses the significance of brain metastases in patients with non–small cell lung cancer.
Watch
Current Research on Identifying Biomarkers in Breast Cancer
March 21st 2018Elizabeth Mittendorf, MD, PhD, director of the Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute, discusses the importance of identifying biomarkers in patients with breast cancer. Current studies are looking at PD-L1 as a possible biomarker, but Mittendorf believes there may be other biomarkers that will prove to be more reliable.
Watch
Results of a Phase II Study of LHRH Therapy in High-Risk Prostate Cancer
March 15th 2018Bridget F. Koontz, MD, associate professor of radiation oncology, Duke Cancer Institute, discusses a single-arm, phase II trial of 6 months of concurrent androgen deprivation therapy/abiraterone acetate (Zytiga) plus prednisone and definitive radiotherapy for men with intermediate- to high-risk localized prostate cancer.
Watch
Choosing Treatment Regimens in Patients with Triple-Negative Breast Cancer
March 14th 2018Hyman B. Muss, MD, professor of medicine, UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill School of Medicine, discusses how he chooses which treatment to use for patients diagnosed with triple-negative breast cancer (TNBC).
Watch
Results for the Combination of Nivolumab and Ibrutinib in Non-Hodgkin Lymphoma and CLL
March 14th 2018Anas Younes, MD, chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, discusses results from a trial studying the combination of nivolumab and ibrutinib for the treatment of patients with relapsed non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Watch
Methods Used for Ovary Suppression in Women with Breast Cancer
March 13th 2018Harold J. Burstein, MD, PhD, a medical oncologist at the Dana-Farber Cancer Institute, explains how ovary suppression is done in patients with breast cancer. This is a particularly important treatment for younger women who still wish to have children one day.
Watch
Using Immunotherapy for the Treatment of mCRC
March 12th 2018Thierry Andre, MD, a professor of medical oncology at the University Pierre et Marie Curie, and Head of the Medical Oncology Department in St. Antoine Hospital, Assistance Publique Hôpitaux de Paris, discusses factors that a community oncologist should consider when choosing the right treatment for patients with metastatic colorectal cancer.
Watch
The Role of Biomarkers in Patients with Breast Cancer
March 8th 2018Susan M. Domchek, MD, director of the Basser Center for BRCA at Penn Medicine, discusses the role biomarkers have in the treatment of patients with breast cancer. Identifying biomarkers in patients early on, such as knowledge of estrogen receptor status, can lead to better treatment plans, Domchek says.
Watch
The Biggest Issue with Treatment of Breast Cancer in Men
March 8th 2018Fatima Cardoso, MD, medical oncologist at the Champalimaud Clinical Centre in Portugal, explains the biggest issue in treatment of male breast cancer is due to lack of education. Male patients are most commonly diagnosed in the advanced stages because of this and are commonly given the wrong treatments, says Cardoso.
Watch